PSS4 COST-EFFECTIVENESS ANALYSIS OF CONBERCEPT VERSUS RANIBIZUMAB FOR THE TREATMENT OF MYOPIC CHOROIDAL NEOVASCULARIZATION (CNV) IN CHINA

Nov 1, 2019, 00:00 AM
10.1016/j.jval.2019.09.2566
https://www.valueinhealthjournal.com/article/S1098-3015(19)34944-7/fulltext
Section Title :
Section Order : 12244
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(19)34944-7&doi=10.1016/j.jval.2019.09.2566
HEOR Topics :
Tags :
Regions :